You are hereOctober 7, 2019
Possible Therapeutic Target for Slow Healing of Aged Muscles Discovered
WASHINGTON, DC (US), October 2019 — An age-related decline in recovery from muscle injury can be traced to a protein that suppresses the special ability of muscle stem cells to build new muscles, according to work from a team of current and former Carnegie Institution biologists led by Chen-Ming Fan, Ph.D.
Skeletal muscles have a tremendous capacity to make new muscles from special muscle stem cells. These “blank” cells are not only good at making muscles but also at generating more of themselves, a process called self-renewal. But their amazing abilities diminish with age, resulting in poorer muscle regeneration from muscle trauma.
The research team — including Carnegie graduate student Liangji Li and Carnegie colleagues Michelle Rozo, Ph.D., Sibiao Yue, Ph.D., Xiaobin Zheng, Ph.D., and Frederick Tan, Ph.D., as well as Christoph Lepper, Ph.D., formerly of Carnegie and now at Ohio State University — figured out that a protein called GAS1 is the culprit for this age-related decline.
“Encoded by the growth-arrest specific gene, the GAS1 protein lives up to its name, accelerating the functional decline of muscle stem cells,” explained Dr. Li, lead author of the study published in Nature Metabolism
The protein is found in only a small number of young muscle stem cells, but is present in all aged muscle stem cells, they discovered. Tinkering with muscle stem cells to express GAS1 in the entire young stem cell population resulted in diminished regeneration. By contrast, removing GAS1 from aged muscle stem cells rejuvenated them to a youthful state that supported robust regeneration.
They also discovered that GAS1 inhibits another protein, a cell-surface receptor called RET, which they showed to be necessary for muscle stem cell renewal. The more GAS1 protein is present, the more RET’s function is reduced.
The inhibition of RET by GAS1 could be reversed by the third protein called GDNF, which binds to and activates RET. Indeed, when the researchers injected GDNF directly into the muscles of aged mice, muscle stem cell function and muscle regeneration were restored.
“With a rapidly aging population, issues like muscle deterioration are an increasing societal challenge,” said Dr. Fan. “Our work could reveal a potential pathway for therapeutic targeting to combat muscle degeneration in the elderly.”
These two photographs show how treatment with the binding-protein GDNF repairs aged muscle stem cells to support robust muscle regeneration. The image on the left shows small muscle fibers (red shapes with blue nuclei inside), which were made by old muscle stem cells. The image on the right shows increased muscle fiber size and muscle stem cell numbers (indicated by green dots) due to GDNF treatment. Image courtesy of Liangji Li.